Update: 19.02.2024
Last week: 6 week 2024 (05.02.2024 - 11.02.2024)
Last full month: January 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 599 | -12.8% | 10.2% | -1.2 | 14 865 639 | -11.7% | 8.8% | -1 | -2.4% |
| MoM | 26 944 | -13.8% | 11.2% | 1.1 | 60 190 108 | -9.5% | 9.7% | 1.2 | -22.4% |
| YTD | 37 844 | 32.0% | 11.0% | 2.3 | 84 634 450 | 64.6% | 9.5% | 2.2 | 4.3% |
| MAT | 350 027 | 35.2% | 9.4% | 1.9 | 690 043 104 | 45.1% | 7.9% | 1.6 | 7.7% |
| BRAINMAX | |||||||||
| WoW | 977 | 7.1% | 100.0% | 0 | 3 572 687 | 9.0% | 100.0% | 0 | 7.1% |
| MoM | 4 282 | -21.7% | 100.0% | 0 | 15 184 484 | -21.8% | 100.0% | 0 | -21.7% |
| YTD | 5 782 | 87.4% | 100.0% | 0 | 20 625 750 | 99.5% | 100.0% | 0 | 87.4% |
| MAT | 49 347 | 271.8% | 100.0% | NA | 171 287 155 | 297.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 16 248 | -2.4% | 43.9% | 0.7 | 51 417 652 | -3.6% | 35.8% | 0.5 | -3.9% |
| MoM | 67 010 | 7.4% | 43.5% | -2.3 | 219 972 521 | 8.7% | 36.1% | -3.2 | 13.2% |
| YTD | 92 757 | 6.5% | 43.5% | 2.5 | 301 863 399 | 15.1% | 36.0% | -0.8 | 0.5% |
| MAT | 874 742 | 23.3% | 45.2% | 2.6 | 2 731 288 631 | 31.4% | 39.5% | 2.6 | 16.1% |
| MIGRENIUM | |||||||||
| WoW | 13 133 | -2.9% | 0.6% | 0 | 3 678 165 | -0.3% | 0.7% | 0 | -2.5% |
| MoM | 49 774 | 6.2% | 0.5% | 0.1 | 13 094 535 | 21.4% | 0.6% | 0.2 | -12.8% |
| YTD | 70 627 | -0.0% | 0.5% | -0.1 | 18 878 611 | 47.9% | 0.6% | 0 | 27.4% |
| MAT | 641 589 | 8.6% | 0.6% | 0 | 128 778 447 | 22.6% | 0.5% | 0 | 7.7% |
| MODELAX-N | |||||||||
| WoW | 30 469 | -1.5% | 22.7% | 0.9 | 12 267 882 | -1.6% | 13.8% | 0.6 | -5.5% |
| MoM | 119 582 | 21.1% | 20.1% | 3.9 | 47 270 565 | 27.9% | 12.0% | 2.8 | -2.4% |
| YTD | 167 672 | 61.9% | 20.7% | 4.7 | 66 640 710 | 95.6% | 12.4% | 2.9 | 25.5% |
| MAT | 1 232 108 | 165.0% | 19.1% | 10.7 | 415 382 432 | 165.4% | 10.7% | 5.9 | 17.3% |
| REDUXIN | |||||||||
| WoW | 12 039 | -9.9% | 32.5% | -2.2 | 65 197 446 | -9.2% | 45.4% | -2.1 | -3.9% |
| MoM | 52 526 | 24.8% | 34.1% | 3.2 | 284 702 122 | 30.8% | 46.8% | 4.5 | 13.2% |
| YTD | 72 131 | -2.6% | 33.9% | -1.1 | 390 537 068 | 24.3% | 46.6% | 2.4 | 0.5% |
| MAT | 635 901 | 3.3% | 32.8% | -4.1 | 2 949 402 612 | 12.9% | 42.7% | -3.8 | 16.1% |
| REDUXIN FORTE | |||||||||
| WoW | 3 471 | 5.6% | 9.4% | 0.8 | 15 845 782 | 8.1% | 11.0% | 1.3 | -3.9% |
| MoM | 12 983 | 5.2% | 8.4% | -0.6 | 56 969 472 | 5.2% | 9.4% | -1.2 | 13.2% |
| YTD | 18 339 | 5.1% | 8.6% | 0.4 | 81 277 125 | 27.1% | 9.7% | 0.7 | 0.5% |
| MAT | 166 900 | 33.0% | 8.6% | 1.1 | 670 823 428 | 41.5% | 9.7% | 1.3 | 16.1% |
| SALVISAR | |||||||||
| WoW | 8 458 | -1.0% | 1.1% | 0 | 3 054 630 | -0.1% | 0.9% | 0 | -2.9% |
| MoM | 33 814 | -10.9% | 1.0% | 0 | 11 736 943 | -6.1% | 0.8% | 0 | -10.4% |
| YTD | 47 160 | -26.5% | 1.1% | -0.6 | 16 543 020 | -19.9% | 0.9% | -0.5 | 13.6% |
| MAT | 481 412 | -24.3% | 1.2% | -0.4 | 159 642 612 | -25.5% | 1.0% | -0.4 | 3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 37 844 | 32.0% | 11.0% | 2.3 | 84 634 450 | 64.6% | 9.5% | 2.2 | 4.3% |
| BRAINMAX | 5 782 | 87.4% | 100.0% | 0 | 20 625 750 | 99.5% | 100.0% | 0 | 87.4% |
| GOLDLINE PLUS | 92 757 | 6.5% | 43.5% | 2.5 | 301 863 399 | 15.1% | 36.0% | -0.8 | 0.5% |
| MIGRENIUM | 70 627 | -0.0% | 0.5% | -0.1 | 18 878 611 | 47.9% | 0.6% | 0 | 27.4% |
| MODELAX-N | 167 672 | 61.9% | 20.7% | 4.7 | 66 640 710 | 95.6% | 12.4% | 2.9 | 25.5% |
| REDUXIN CAPS | 72 131 | -2.6% | 33.9% | -1.1 | 390 537 068 | 24.3% | 46.6% | 2.4 | 0.5% |
| REDUXIN FORTE | 18 339 | 5.1% | 8.6% | 0.4 | 81 277 125 | 27.1% | 9.7% | 0.7 | 0.5% |
| SALVISAR | 47 160 | -26.5% | 1.1% | -0.6 | 16 543 020 | -19.9% | 0.9% | -0.5 | 13.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 350 027 | 35.2% | 9.4% | 1.9 | 690 043 104 | 45.1% | 7.9% | 1.6 | 7.7% |
| BRAINMAX | 49 347 | 271.8% | 100.0% | NA | 171 287 155 | 297.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | 874 742 | 23.3% | 45.2% | 2.6 | 2 731 288 631 | 31.4% | 39.5% | 2.6 | 16.1% |
| MIGRENIUM | 641 589 | 8.6% | 0.6% | 0 | 128 778 447 | 22.6% | 0.5% | 0 | 7.7% |
| MODELAX-N | 1 232 108 | 165.0% | 19.1% | 10.7 | 415 382 432 | 165.4% | 10.7% | 5.9 | 17.3% |
| REDUXIN CAPS | 635 901 | 3.3% | 32.8% | -4.1 | 2 949 402 612 | 12.9% | 42.7% | -3.8 | 16.1% |
| REDUXIN FORTE | 166 900 | 33.0% | 8.6% | 1.1 | 670 823 428 | 41.5% | 9.7% | 1.3 | 16.1% |
| SALVISAR | 481 412 | -24.3% | 1.2% | -0.4 | 159 642 612 | -25.5% | 1.0% | -0.4 | 3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 599 | -12.8% | 10.2% | -1.2 | 14 865 639 | -11.7% | 8.8% | -1 | -2.4% |
| BRAINMAX | 977 | 7.1% | 100.0% | 0 | 3 572 687 | 9.0% | 100.0% | 0 | 7.1% |
| GOLDLINE PLUS | 16 248 | -2.4% | 43.9% | 0.7 | 51 417 652 | -3.6% | 35.8% | 0.5 | -3.9% |
| MIGRENIUM | 13 133 | -2.9% | 0.6% | 0 | 3 678 165 | -0.3% | 0.7% | 0 | -2.5% |
| MODELAX-N | 30 469 | -1.5% | 22.7% | 0.9 | 12 267 882 | -1.6% | 13.8% | 0.6 | -5.5% |
| REDUXIN CAPS | 12 039 | -9.9% | 32.5% | -2.2 | 65 197 446 | -9.2% | 45.4% | -2.1 | -3.9% |
| REDUXIN FORTE | 3 471 | 5.6% | 9.4% | 0.8 | 15 845 782 | 8.1% | 11.0% | 1.3 | -3.9% |
| SALVISAR | 8 458 | -1.0% | 1.1% | 0 | 3 054 630 | -0.1% | 0.9% | 0 | -2.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 26 944 | -13.8% | 11.2% | 1.1 | 60 190 108 | -9.5% | 9.7% | 1.2 | -22.4% |
| BRAINMAX | 4 282 | -21.7% | 100.0% | 0 | 15 184 484 | -21.8% | 100.0% | 0 | -21.7% |
| GOLDLINE PLUS | 67 010 | 7.4% | 43.5% | -2.3 | 219 972 521 | 8.7% | 36.1% | -3.2 | 13.2% |
| MIGRENIUM | 49 774 | 6.2% | 0.5% | 0.1 | 13 094 535 | 21.4% | 0.6% | 0.2 | -12.8% |
| MODELAX-N | 119 582 | 21.1% | 20.1% | 3.9 | 47 270 565 | 27.9% | 12.0% | 2.8 | -2.4% |
| REDUXIN CAPS | 52 526 | 24.8% | 34.1% | 3.2 | 284 702 122 | 30.8% | 46.8% | 4.5 | 13.2% |
| REDUXIN FORTE | 12 983 | 5.2% | 8.4% | -0.6 | 56 969 472 | 5.2% | 9.4% | -1.2 | 13.2% |
| SALVISAR | 33 814 | -10.9% | 1.0% | 0 | 11 736 943 | -6.1% | 0.8% | 0 | -10.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs